Langer Oded, Miodovnik Menachem, Reece E Albert, Rosenn Barak M
Department of Obstetrics and Gynecology, St. Luke's-Roosevelt Hospital Center, New York, NY, USA.
J Matern Fetal Neonatal Med. 2010 Mar;23(3):196-8. doi: 10.3109/14767050903550634.
The DPSG of North America (DPSG-NA) was inaugurated in 1997, and its initial meeting was commenced in San Antonio, Texas, in 1998. Since then, the DPSG-NA has held annual meetings, which are hosted by the home institution of members of the organizing committee on a rotating basis. This yeas, the DPSG-NA held its 11 annual meeting in Baltimore, Maryland, and focused on the major controversies regarding the detection, diagnosis, and management of gestational diabetes mellitus (GDM). It included the latest information on the maternal and fetal consequences of GDM as well as summaries from the HAPO study, the Australian Carbohydrate Intolerance Study (ACHOIS) in pregnant women, and the National Institute of Child Health and Human Development Maternal Fetal Medicine (NICHD MFMU Network) study. In addition, extensive data were presented on the effectiveness of oral antihyperglycemic agents in managing GDM as well as data from studies examining their transfer across the placenta and effects on the fetus. Strategies for managing hypertensive disorders associated with GDM were also presented. Based on this year's presentations, the DPSG-NA coordinating committee has made recommendations on the screening and management of GDM and priorities for future research.
北美糖尿病妊娠研究组（DPSG - NA）于1997年成立，其首次会议于1998年在得克萨斯州圣安东尼奥召开。从那时起，DPSG - NA每年都会召开会议，由组委会成员所在机构轮流主办。今年，DPSG - NA在马里兰州巴尔的摩举行了第11届年会，会议聚焦于妊娠糖尿病（GDM）检测、诊断和管理方面的主要争议。会议内容包括GDM对母婴影响的最新信息，以及高血糖与不良妊娠结局研究（HAPO）、澳大利亚孕妇碳水化合物不耐受研究（ACHOIS）和美国国立儿童健康与人类发展研究所母胎医学网络（NICHD MFMU Network）研究的总结。此外，还展示了关于口服降糖药治疗GDM有效性的数据，以及有关药物经胎盘转运及其对胎儿影响的研究数据。会上还介绍了GDM相关高血压疾病的管理策略。基于今年的报告，DPSG - NA协调委员会对GDM的筛查和管理以及未来研究重点提出了建议。
